Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.

Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.

Zobrazit další vydání (1)

There is a growing recognition of the importance of protein kinases in the control of alternative splicing. To define the underlying regulatory mechanisms, highly selective inhibitors are needed. Here, we report the discovery and characterization of the dichloroindolyl enaminonitrile KH-CB19, a pote...

Podrobná bibliografie
Hlavní autoři:	Fedorov, O, Huber, K, Eisenreich, A, Filippakopoulos, P, King, O, Bullock, A, Szklarczyk, D, Jensen, L, Fabbro, D, Trappe, J, Rauch, U, Bracher, F, Knapp, S
Médium:	Journal article
Jazyk:	English
Vydáno:	2011

Podobné jednotky

Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.
Autor: Fedorov, O, a další
Vydáno: (2011)

7,8-dichloro-1-oxo-β-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes.
Autor: Huber, K, a další
Vydáno: (2012)

Regulation of influenza A virus mRNA splicing by CLK1
Autor: Artarini, A, a další
Vydáno: (2019)

CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors
Autor: Fernando Salvador, a další
Vydáno: (2018-05-01)

Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2
Autor: Maya L Bulos, a další
Vydáno: (2023-12-01)

Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.
Autor: Bullock, A, a další
Vydáno: (2009)

Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation
Autor: Bullock, A, a další
Vydáno: (2009)

Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells
Autor: Elizabeth Bowler, a další
Vydáno: (2018-04-01)

Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.
Autor: Debdab, M, a další
Vydáno: (2011)

Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
Autor: Kenichi Iwai, a další
Vydáno: (2018-05-01)

Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing.
Autor: Shinsuke Araki, a další
Vydáno: (2015-01-01)

DFG-1 residue controls inhibitor binding mode and affinity, providing a basis for rational design of kinase inhibitor selectivity
Autor: Schröder, M, a další
Vydáno: (2020)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
Autor: Filippakopoulos, P, a další
Vydáno: (2012)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
Autor: Filippakopoulos, P, a další
Vydáno: (2012)

Clk/STY (cdc2-like kinase 1) and Akt regulate alternative splicing and adipogenesis in 3T3-L1 pre-adipocytes.
Autor: Pengfei Li, a další
Vydáno: (2013-01-01)

CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics
Autor: Vincent Geoghegan, a další
Vydáno: (2022-11-01)

Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases
Autor: Viet Hung Dao, a další
Vydáno: (2021-10-01)

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression
Autor: Jasper Van Goubergen, a další
Vydáno: (2025-02-01)

Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors.
Autor: Aiko Murai, a další
Vydáno: (2020-01-01)

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
Autor: Walter, A, a další
Vydáno: (2018)

5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency
Autor: Ahmed K. ElHady, a další
Vydáno: (2021-02-01)

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.
Autor: Anne Walter, a další
Vydáno: (2018-01-01)

Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission.
Autor: Selina Kern, a další
Vydáno: (2014-01-01)

Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
Autor: Pogacic, V, a další
Vydáno: (2007)

CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor
Autor: Tyler Funnell, a další
Vydáno: (2017-02-01)

Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.
Autor: Shamila S Gunatilleke, a další
Vydáno: (2012-01-01)

Multicomponent mapping of boron chemotypes furnishes selective enzyme inhibitors
Autor: Joanne Tan, a další
Vydáno: (2017-11-01)

CLK3 promotes tumor proliferation by activating MYC signaling
Autor: Jing Shen, a další
Vydáno: (2024-09-01)

Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes
Autor: Lori Ferrins, a další
Vydáno: (2023-05-01)

Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
Autor: Popp, T, a další
Vydáno: (2016)

CLK2 Condensates Reorganize Nuclear Speckles and Induce Intron Retention
Autor: Bing Wang, a další
Vydáno: (2024-10-01)

Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors.
Autor: Christian Schmitt, a další
Vydáno: (2014-01-01)

The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
Autor: Hay, D, a další
Vydáno: (2013)

Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes
Autor: Lori Ferrins, a další
Vydáno: (2023-10-01)

Discrimination of fennel chemotypes applying IR and Raman spectroscopy – discovery of a new -asarone chemotype
Autor: Krähmer, Andrea, a další
Vydáno: (2016-07-01)

Calculation of Splicing Potential from the Alternative Splicing Mutation Database
Autor: Afonin Kirill A, a další
Vydáno: (2008-02-01)

Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction
Autor: Rooney, T, a další
Vydáno: (2012)

The Alternative Splicing Mutation Database: a hub for investigations of alternative splicing using mutational evidence
Autor: Afonin Kirill A, a další
Vydáno: (2008-02-01)

Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency
Autor: Subha Dahal, a další
Vydáno: (2022-08-01)

In depth investigation of the metabolism of Nectandra megapotamica chemotypes.
Autor: Katyuce de S Farias, a další
Vydáno: (2018-01-01)